论文部分内容阅读
中共中央、国务院印发的《“健康中国2030”规划纲要》指出,医药产业要加强疾病预防、新药研发;把精准医疗、生物治疗等作为重点发展方向;同时要加强中药创新。抗肿瘤药物在重大疾病防治以及创新药物研发领域始终走在前沿。随着国家新药创制重大专项资金的大量投入,抗肿瘤药物药物研发工作持续升温,并产生了许多具国际领先水平的科研成果。近年来,根据肿瘤生物学特点发展起来的精准
The Outline of the 2030 Plan for Healthy China promulgated by the CPC Central Committee and the State Council pointed out that the pharmaceutical industry should step up its efforts in disease prevention and research and development of new drugs, put precision medical treatment and biological treatment as key development directions, and at the same time, innovate traditional Chinese medicines. Anti-cancer drugs in the prevention and treatment of major diseases and innovative drug research and development has always been in the forefront. With the massive investment of major national special funds for new drug creation, research and development of anti-cancer drug drugs continue to heat up and many scientific research achievements with international advanced level have been produced. In recent years, according to the characteristics of tumor biology developed precision